Asthma Classification: Intermittent Asthma
This patient has intermittent asthma based on the single exacerbation within the past year and minimal to no regular medication use. 1
Classification Rationale
According to the NAEPP Expert Panel Report 3 (EPR-3) guidelines, asthma severity is determined by assessing both impairment (day-to-day symptoms and functional limitations) and risk (likelihood of future exacerbations). 1 The classification is assigned to the most severe category in which any feature occurs. 1
Key Classification Criteria for This Patient:
Risk Domain - Exacerbations:
- 0-1 exacerbations per year requiring oral systemic corticosteroids = Intermittent asthma 1
- This patient had 1 attack one month ago, placing them in the intermittent category based on risk assessment 1
Impairment Domain - Medication Use:
- The patient does not use albuterol regularly or frequently (≤2 days per week for symptom control) 1
- No regular controller medication use suggests minimal day-to-day symptoms 1
- These features are consistent with intermittent asthma: symptoms ≤2 days per week, nighttime awakenings ≤2 times per month, and no interference with normal activity 1
Critical Guideline Distinction
The EPR-3 guidelines specifically state that patients with ≥2 exacerbations requiring oral systemic corticosteroids in the past year should be considered to have persistent asthma, even if all impairment features suggest intermittent disease. 1 Since this patient had only 1 exacerbation, they do not meet this threshold for automatic reclassification to persistent asthma. 1
Important Clinical Caveats
Verify the complete clinical picture before finalizing classification:
- Confirm the patient truly has minimal symptoms (≤2 days/week) and not just poor symptom recognition 1
- Assess whether the recent attack was truly isolated or part of a pattern of worsening control 1
- Determine if the patient is underusing medications due to good control versus poor access, adherence, or symptom perception 1
If any of the following are present, reclassification to persistent asthma may be warranted:
- Symptoms >2 days per week 1
- Nighttime awakenings 3-4 times per month or more 1
- Any limitation of normal activities due to asthma 1
- FEV₁ <80% predicted or FEV₁/FVC ratio reduced >5% 1
Patients and physicians commonly underestimate asthma severity—39-70% of patients with moderate symptoms believe their asthma is well-controlled. 1 Therefore, systematic assessment using objective criteria rather than patient perception alone is essential. 1